Vertex Pharmaceuticals Incorporated announced that 65% of people overall achieved a sustained viral response (viral cure) with a telaprevir-based regimen in the Phase 3 REALIZE study, compared to 17% of people who received pegylated-interferon and ribavirin alone.
A federal jury in New Hampshire has awarded $21 million to a woman blinded and scarred by a prescription drug she took for shoulder pain.
The planned buyout of Trubion Pharmaceuticals Inc. by Emergent BioSolutions Inc. cleared a regulatory hurdle, bringing the deal, potentially worth $135.5 million, closer to closing.
Health giant Johnson & Johnson is donating about $200 million in cash and medicine to a sweeping United Nations program created to improve the health and lives of people in poor countries.
With the software solutions Ariol and SlidePath, Leica Microsystems now adds the ability to store, manage, analyze, and report on digital images created with the Leica SCN400 Slide Scanner or the Leica DM6000 B Research Microscope.
ForteBio, Inc., a supplier of label-free technology, announced the launch of its Dip and Read Protein G biosensor for rapid detection and quantification of numerous types of mammalian immunoglobulin, from solution.
Zyleris PharmaTech has announced the launch of its high-throughput formulation screening service for topical and transdermal drug development based on the company’s innovative experimentation technology.
Protea Biosciences announced that the company has concluded an exclusive, worldwide license agreement with George Washington University for commercial rights to a new technology that provides rapid identification of a broad range of chemicals and biomolecules.
One such obstacle frustrating stem cell researchers is "cell death" that the major types of hPS cells, including human embryonic stem cells and human induced pluripotent stem cells, mysteriously undergo when cultured as single cells, rendering them less suitable for research.
Using high-resolution microscopy, researchers at the National Institutes of Health have shown how insulin prompts fat cells to take in glucose in a rat model.
Cumberland Pharmaceuticals Inc. announced the publication of new data supporting the safety and efficacy of Caldolor (ibuprofen) Injection in pre- and post-operative orthopedic surgery patients.
DARA BioSciences announced that it presented study results from its Phase 2 multicenter, placebo controlled, double-blind, randomized dose escalation study for KRN5500 at the 13th World Congress on Pain held recently in Montreal.
To help advance research on how genes affect responses to medicines, the National Institutes of Health is spending $15 million over five years to expand a key resource, the Pharmacogenomics Knowledge Base (PharmGKB).
Merck & Co. said its schizophrenia drug Saphris has been approved for two additional uses by the Food and Drug Administration.
If you thought passing the health care overhaul was messy, wait until Republicans try to repeal it if they regain power this fall. It could come down to who blinks first, with some Republicans raising the prospect of a government shutdown.